Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research

Publisher： John Wiley & Sons Inc

E-ISSN： 1748-720x|43|3|619-632

ISSN： 1073-1105

Source： THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol.43, Iss.3, 2015-09, pp. : 619-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Returning a Research Participant's Genomic Results to Relatives: Perspectives from Managers of Two Distinct Research Biobanks

By  

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. 3, 2015-09 ,pp. : 523-528

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stem cells: progress in research and edging towards the clinical setting

By Stanworth Simon J   Newland Adrian C  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 378-382

Royal College Of Physicians

Access to resources Recommend Favorite

On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing

By  

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. 1, 2015-03 ,pp. : 134-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exceptional Matters: clinical research from bedside to bench

By Peters Keith  

Clinical Medicine, Vol. 4, Iss. 6, 2004-11 ,pp. : 551-566

Royal College Of Physicians

Access to resources Recommend Favorite

Medicinal drugs and driving: from research to clinical practice

By Javier Alvarez F.   Carmen del Ro M.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 9, 2002-09 ,pp. : 441-443

Elsevier

Access to resources Recommend Favorite